Amphastar Pharma Balance Sheet - Quarterly (NASDAQ:AMPH)

Add to My Stocks
$16.1 $0.4 (2.42%) AMPH stock closing price Jun 21, 2018 (Closing)

The financial analysis of a company like Amphastar Pharma involves checking the three financial statements of the company in detail, of which the balance sheet is one. How cash on hand has increased or decreased is one of the many indicators used while undertaking the Amphastar Pharma stock analysis, and provides insights into the firm's financial performance. Good quarterly results indicate a company's strong financial performance. Its important to check all financial statements including the balance sheet. Apart from analyzing Amphastar Pharma revenue Amphastar Pharma operating cash flow, one needs to check balance sheet items like cash, fixed assets and debt. The Amphastar Pharma balance sheet for 2018 Q1 shows cash on hand of $54.54M. The company has a debt to equity ratio of 0.14.

View and download Amphastar Pharma quarterly results to get the balance sheet details for the latest 40 quarters data.
show more
Quarterly
Annual
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q4
Cash54.54M65.59M66.92M82.54M76.76M72.35M66.59M66.66M63.33M66.07M
Marketable Securities6.98M6.79M6.67M4.88M2.26M1.91M2.24M1.39M1.28M1.28M
Receivables44.07M42.03M24.59M24.5M26.1M26.79M26.7M23.18M23.49M33.47M
Inventory62.78M63.6M69.64M74.45M78.13M79.75M90.65M88.32M82.24M70.66M
Raw Materials22.27M19.97M22M24.91M33.48M36.2M47.24M42.57M38.13M31.87M
Work In Progress21.79M22.46M24.78M26.51M23.99M22.26M15.64M16.65M19.93M21.45M
Finished Goods18.71M21.16M22.85M23.02M20.66M21.27M29.35M30.73M26.39M19.86M
Notes Receivable----------
Other Current Assets5.66M9.75M8.66M7.18M8.14M3.27M3.98M1.75M3.09M4.43M
Total Current Assets
174.04M187.77M176.49M193.57M191.41M184.09M190.18M181.31M173.44M175.93M
Property Plant & Equipment328.51M318.66M303.42M289.18M281.72M274.95M271.4M265.35M259.67M254.41M
Accumulated Depreciation136.59M133.32M130.38M127.46M124.33M122.01M119.44M116.7M114.99M112.25M
Net Property Plant & Equipment
191.91M185.33M173.04M161.72M157.38M152.94M151.95M148.64M144.68M142.16M
Investment & Advances----------
Other Non-Current Assets----------
Deferred Charges28.25M27.74M31.87M31.87M31.87M31M27.42M27.44M27.44M27.44M
Intangibles44.85M45.14M45.73M45.86M45.99M50.3M51.73M43.29M44.02M39.9M
Deposits & Other Assets10.71M8.66M10.62M10.95M8.93M9.39M7.54M7.88M5.41M4.69M
Total Assets
449.78M454.66M437.76M443.99M435.61M427.73M428.83M408.58M395M390.13M
Notes Payable----------
Accounts Payable58.49M57.55M9.59M14.91M19.3M16.19M13.43M18.76M18.61M13.87M
Current Portion Long-Term Debt6.06M6.31M6.21M6.2M5.26M5.36M8.54M10.9M11.17M10.93M
Current Portion Capital Leases----------
Accrued Expenses--37.41M36.36M40.19M31.35M31.81M27.68M30.22M31.43M
Income Taxes Payable7.98M3.32M4.18M6.22M8.09M7.7M6.21M6.65M4.25M3.07M
Other Current Liabilities-------1.66M--
Total Current Liabilities
72.54M67.19M57.39M63.7M72.86M60.61M60.83M65.66M64.92M59.95M
Mortgages----------
Deferred Taxes/Income1.42M1.36M2.8M1.96M1.75M1.55M1.78M-1.17M1.33M
Convertible Debt----------
Long-Term Debt39.7M40.84M42.23M40.1M31.14M32.35M34.16M31.74M29.09M30.16M
Non-Current Capital Leases----------
Other Long-Term Liabilities9M7.93M4.68M4.91M4.28M3.95M3.6M3.54M3.22M3.16M
Total Liabilities
122.67M117.33M107.11M110.68M110.05M98.48M100.38M101.12M98.42M94.62M
Minority Interest----------
Preferred Stock----------
Common Stock Net----------
Capital Surplus316.66M313.89M303.2M299.1M285.35M283.12M276.54M258.78M250.68M247.82M
Retained Earnings69.57M76.23M74.76M74.59M72.62M70.85M73.59M69.7M62.81M60.32M
Treasury Stock58.22M50.7M44.73M37.16M28.19M20.03M19.11M18.34M14.87M10.17M
Other Liabilities-0.91M-2.1M-2.59M-3.22M-4.23M-4.69M-2.58M-2.69M-2.03M-2.47M
Shareholders Equity327.1M337.32M330.65M333.31M325.56M329.25M328.45M307.46M296.58M295.51M
Total Liabilities & Shareholders Equity449.78M454.66M437.76M443.99M435.61M427.73M428.83M408.58M395M390.13M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

Most investors just check the Amphastar Pharma stock price, and Amphastar Pharma historical stock prices before investing. While share price is an important factor, one should also look at financials and valuation metrics like the Amphastar Pharma PE ratio chart. Below is a brief explanation of common balance sheet terms:

  • Assets: Anything that the Amphastar Pharma company owns and is a part of its books. Assets can be of three types: fixed, current and other assets which includes intangibles, advances. Internet companies typically don't have a lot of assets as there is not much investment in say machinery, equipment etc. Amphastar Pharma had total assets of $449.78M.
  • Liabilities or obligations comprise of current liabilities that include short term loans, amounts payable to suppliers, or any other outstanding payments including long term liabilities that take into account long term loans for funding large projects. The total liabilities for Amphastar Pharma is $122.67M. Shareholders equity comes under liabilities as it is money the company owes the holders of AMPH stock.

Amphastar Pharma Balance Sheet - Key Ratios

Current ratio
2.4
Debt to equity ratio
0.14
Asset turnover ratio
0.52
Receivables turnover
7.5
Price to book ratio
2.32